Patent: 5,116,952
✉ Email this page to a colleague
Summary for Patent: 5,116,952
Title: | Protein active in humoral hypercalcemia of malignancy-PTHRP |
Abstract: | Substantially pure proteins active in humoral hypercalcemia of malignancy (PTHrP) and sub-units and fragments thereof. Antibody reagents capable of binding to epitopes of PTHrP. Methods and kits for the detection of PTHrP. |
Inventor(s): | Martin; Thomas J. (Kew, AU), Moseley; Jane M. (North Balwyn, AU), Kemp; Bruce E. (Kew, AU), Wettenhall; Richard E. H. (Camberwell, AU) |
Assignee: | The University of Melbourne (Victoria, AU) |
Application Number: | 07/199,235 |
Patent Claims: | see list of patent claims |
Details for Patent 5,116,952
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2009-05-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |